Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

60.23 +1.81 (+3.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

43 44 Next >

Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices ↗

March 02, 2023

The decision came months ahead of Dexcom's and Abbott's expectations.

Via Investor's Business Daily

Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years ↗

March 02, 2023

Via Benzinga

Where to Invest $1,000 in a 2023 Nasdaq Bear Market ↗

March 02, 2023

Even a modest investment in great companies can pay off over the long run.

Via The Motley Fool

Should Abbott and DexCom Investors Be Worried About Apple's Latest News? ↗

February 28, 2023

The continuous glucose monitoring market could heat up.

Via The Motley Fool

What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?

February 28, 2023

DarioHealth (NASDAQ: DRIO) Partners With Dexcom (NASDAQ: DXCM) The Global Leader in Continuous Glucose Monitoring (CGM) To Integrate Dario's Multi-Chronic Condition Platform.

Via News Direct

Better Buy: Abbott Laboratories or DexCom Stock? ↗

February 24, 2023

Both stocks should benefit from the growth in diabetes care.

Via The Motley Fool

2 No-Brainer Growth Stocks to Buy Right Now ↗

February 19, 2023

Don't let these incredible businesses pass you by.

Via The Motley Fool

Looking Into DexCom's Return On Capital Employed ↗

February 13, 2023

Via Benzinga

Analyst Ratings for DexCom ↗

February 10, 2023

Via Benzinga

DexCom (DXCM) Q4 2022 Earnings Call Transcript ↗

February 09, 2023

DXCM earnings call for the period ending December 31, 2022.

Via The Motley Fool

2 Stock-Split Stocks with Explosive Potential to Buy in 2023 ↗

February 24, 2023

Don't let these top stocks pass you by.

Via The Motley Fool

Dexcom Announces Upcoming Conference Presentations

February 23, 2023

From DexCom, Inc.

Via Business Wire

Dexcom Slumps As A New Rival Reportedly Arrives On Scene: Apple ↗

February 22, 2023

Apple is reportedly making a bid for the diabetes market with new Apple Watch tech.

Via Investor's Business Daily

What Does Apple Have To Do With DexCom Stock Trading Lower? ↗

February 22, 2023

DexCom shares (NASDAQ: DXCM) are trading lower on Wednesday following a report that Apple Inc (NASDAQ: AAPL) is making progress on no-prick glucose tracking for its Watch.

Via Benzinga

My 3 Biggest Stock Market Predictions for March ↗

February 21, 2023

These three trends will likely drive revenue and share prices.

Via The Motley Fool

Dexcom Advances On Fourth-Quarter Beat, Reiterates Its 2023 Sales Expectations ↗

February 09, 2023

Shares rose closer to a buy point in late action Thursday.

Via Investor's Business Daily

A Preview Of DexCom's Earnings ↗

February 08, 2023

Via Benzinga

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

February 21, 2023

These stocks have something to offer every type of investor.

Via The Motley Fool

2 Exceptional Growth Stocks Billionaires Keep Buying With Both Hands ↗

February 20, 2023

A poor performance from the broad market didn't stop these billionaire hedge fund managers from placing big bets on three supercharged growth stocks.

Via The Motley Fool

2 Healthcare Stocks You Can Buy and Hold for the Next Decade ↗

February 19, 2023

This healthcare space is bursting with opportunity for long-term investors.

Via The Motley Fool

Deere Leads 5 Stocks With Hot Products Near Buy Points ↗

February 18, 2023

Deere and Dexcom lead this weekend list of 5 stocks near buy points.

Via Investor's Business Daily

2 Growth Stocks That Could Help Make You a Fortune ↗

February 13, 2023

These companies have what it takes to deliver outsized returns over the long haul.

Via The Motley Fool

Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them ↗

February 13, 2023

Super Bowl LVII aired Sunday Feb. 12, 2023 and featured dozens of commercials advertising products and showcasing new movies and television shows. The commercials also featured many celebrity cameos...

Via Benzinga

Cramer: This Big US Bank Stock Can 'Go Much Higher In This Environment' ↗

February 13, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said A. O.

Via Benzinga

Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch

February 13, 2023

From Dexcom, Inc.

Via Business Wire

2 Top Healthcare Stocks to Buy for the Long Haul ↗

February 13, 2023

The healthcare industry is booming, and this presents no shortage of opportunities to invest in promising businesses.

Via The Motley Fool

Stock Market Pulls Back As Treasury Yields Jump; Google Dives On AI Flop: Weekly Review ↗

February 10, 2023

Is this a normal, healthy pullback or the start of something more?

Via Investor's Business Daily

Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday ↗

February 10, 2023

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

The Super Bowl LVII Commercials List: From A Breaking Bad Reunion To Ozzy Osbourne, The Celebrities And 21 Stocks To Watch ↗

February 10, 2023

A 30-second commercial during Super Bowl LVII costs around $7 million. For some companies hoping to increase their brand recognition or introduce a new product, the price is worth it.

Via Benzinga

Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results

February 09, 2023

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

43 44 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today